Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

[1] Gabriel SE(1991)Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis Ann Intern Med 115 787-796

[2] Jaakkimainen L(1991)Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage Am J Gastroenterol 86 961-964

[3] Bombardier C(1991)Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models Am J Med 91 213-222

[4] Bellary SV(2008)ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Am J Gastroenterol 103 2890-2907

[5] Isaacs PE(1998)Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs: omeprazole versus misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group N Engl J Med 338 727-734

[6] Lee FI(1998)A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs: acid suppression trial: ranitidine versus omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group N Engl J Med 338 719-726

[7] Fries JF(2002)Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole Arch Intern Med 162 169-175

[8] Williams CA(1996)Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study Am J Gastroenterol 91 223-227

[9] Bloch DA(2003)Lansoprazole reduces ulcer relapse after eradication of Aliment Pharmacol Ther 18 829-836

[10] Bhatt DL(2007) in nonsteroidal anti-inflammatory drug users—a randomized trial J Clin Biochem Nutr 40 148-155

[1] Gabriel SE(1991)Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis Ann Intern Med 115 787-796

[2] Jaakkimainen L(1991)Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage Am J Gastroenterol 86 961-964

[3] Bombardier C(1991)Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models Am J Med 91 213-222

[4] Bellary SV(2008)ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Am J Gastroenterol 103 2890-2907

[5] Isaacs PE(1998)Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs: omeprazole versus misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group N Engl J Med 338 727-734

[6] Lee FI(1998)A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs: acid suppression trial: ranitidine versus omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group N Engl J Med 338 719-726

[7] Fries JF(2002)Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole Arch Intern Med 162 169-175

[8] Williams CA(1996)Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study Am J Gastroenterol 91 223-227

[9] Bloch DA(2003)Lansoprazole reduces ulcer relapse after eradication of Aliment Pharmacol Ther 18 829-836

[10] Bhatt DL(2007) in nonsteroidal anti-inflammatory drug users—a randomized trial J Clin Biochem Nutr 40 148-155